SOLESENCE, INC. — Director's Dealing 2024

Jan 24, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOPHASE TECHNOLOGIES Corp (NANX)
CIK: 0000883107
Period of Report: 2024-01-23

Reporting Person: Cureton Kevin (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-01-23	Common Stock	M	25000	$0.52	Acquired	125821	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-01-23	Common Stock (right to purchase)	$0.52	D	25000	Disposed	2024-02-13	Common Stock (25000)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Common Stock (right to purchase)	$0.44	2025-02-18	Common Stock (50000)	50000	Direct
Common Stock (right to purchase)	$0.42	2026-02-23	Common Stock (43500)	43500	Direct
Common Stock (right to purchase)	$0.68	2027-02-21	Common Stock (50000)	50000	Direct
Common Stock (right to purchase)	$0.82	2028-05-23	Common Stock (80000)	80000	Direct
Common Stock (right to purchase)	$0.51	2029-05-22	Common Stock (16500)	16500	Direct
Common Stock (right to purchase)	$0.45	2027-06-18	Common Stock (90000)	90000	Direct
Common Stock (right to purchase)	$4.17	2028-12-28	Common Stock (90000)	90000	Direct
Common Stock (right to purchase)	$1.165	2029-12-20	Common Stock (72000)	72000	Direct
Common Stock (right to purchase)	$0.61	2030-12-27	Common Stock (12600)	12600	Direct

Footnotes

F1: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.